Literature DB >> 23960151

Sustained antidepressant response to ketamine.

Onome Victor Atigari1, David Healy.   

Abstract

Case series outlining the treatment of three patients with ketamine, in which two of the patients had a sustained antidepressant effect to ketamine without the need for maintenance on antidepressants. These two responders have an established diagnosis of bipolar affective disorder with a history of response to electroconvulsive therapy and lithium, both of which have an influence on the seizure threshold as has ketamine. The mechanism of action of ketamine is yet unclear and although the current focus is on the N-methyl-d-aspartate and alpha-amino-3-4-hydroxy-5methyl-4-isoxazoleproprionic acid receptors, we additionally recommend that its impact on the seizure threshold should be explored with a view to fully elucidating the mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23960151      PMCID: PMC3762430          DOI: 10.1136/bcr-2013-200370

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Pro-convulsant effects: a neglected dimension of psychotropic activity.

Authors:  Onome Atigari; David Healy
Journal:  Aust N Z J Psychiatry       Date:  2013-06-24       Impact factor: 5.744

2.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

Review 3.  Ketamine as a novel antidepressant: from synapse to behavior.

Authors:  J W Murrough
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

4.  A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.

Authors:  Carlos A Zarate; Daniel Mathews; Lobna Ibrahim; Jose Franco Chaves; Craig Marquardt; Immaculata Ukoh; Libby Jolkovsky; Nancy E Brutsche; Mark A Smith; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

5.  GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Katherine L Nicholson; Robert L Balster; J David Leander; Patric K Stanton; Amanda L Gross; Roger A Kroes; Joseph R Moskal
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

  5 in total
  1 in total

1.  Ketamine for Bipolar Depression: A Systematic Review.

Authors:  Anees Bahji; Carlos A Zarate; Gustavo H Vazquez
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-23       Impact factor: 5.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.